Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infection
Fubing Li, … , Ceshi Chen, Xiaopeng Qi
Fubing Li, … , Ceshi Chen, Xiaopeng Qi
Published June 19, 2018
Citation Information: J Clin Invest. 2018;128(9):4148-4162. https://doi.org/10.1172/JCI120406.
View: Text | PDF
Research Article Immunology Infectious disease

HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infection

  • Text
  • PDF
Abstract

Lysine-63–linked (K63-linked) polyubiquitination of TRAF3 coordinates the engagement of pattern-recognition receptors with recruited adaptor proteins and downstream activator TBK1 in pathways that induce type I IFN. Whether autoubiquitination or other E3 ligases mediate K63-linked TRAF3 polyubiquitination remains unclear. We demonstrated that mice deficient in the E3 ligase gene Hectd3 remarkably increased host defense against infection by intracellular bacteria Francisella novicida, Mycobacterium, and Listeria by limiting bacterial dissemination. In the absence of HECTD3, type I IFN response was impaired during bacterial infection both in vivo and in vitro. HECTD3 regulated type I IFN production by mediating K63-linked polyubiquitination of TRAF3 at residue K138. The catalytic domain of HECTD3 regulated TRAF3 K63 polyubiquitination, which enabled TRAF3-TBK1 complex formation. Our study offers insights into mechanisms of TRAF3 modulation and provides potential therapeutic targets against infections by intracellular bacteria and inflammatory diseases.

Authors

Fubing Li, Yang Li, Huichun Liang, Tao Xu, Yanjie Kong, Maobo Huang, Ji Xiao, Xi Chen, Houjun Xia, Yingying Wu, Zhongmei Zhou, Xiaomin Guo, Chunmiao Hu, Chuanyu Yang, Xu Cheng, Ceshi Chen, Xiaopeng Qi

×

Figure 1

Hectd3–/– mice are resistant to F. novicida infection.

Options: View larger image (or click on image) Download as PowerPoint

Hectd3–/– mice are resistant to F. novicida infection.
(A) Hectd3–/– mi...
(A) Hectd3–/– mice (n = 9) and littermate WT controls (n = 9) were infected subcutaneously with 3.0 × 105 CFUs of F. novicida, and survival was monitored. (B) Body weight of WT and Hectd3–/– mice after F. novicida infection as in A, presented relative to the starting body weight at day 0, which was set as 100%. (C) Hectd3–/– mice and littermate WT controls were infected subcutaneously with 3.0 × 105 CFUs of F. novicida, and bacterial burden in the spleen, liver, and lung on day 2 after infection was measured. (D) H&E staining of liver sections from WT and Hectd3–/– mice on day 2 after infection with F. novicida. Arrowheads indicate infiltrated immune cells. (E) Ly-6G immunohistochemical staining of spleen and liver sections from WT and Hectd3–/– mice on day 2 after infection with F. novicida. Arrowheads indicate neutrophil recruitment. Scale bars: 50 μm. (F and G) Expression of genes encoding TNF-α, IL-6, and IFN-β (F) and production of TNF-α, IL-6, and IFN-β (G) were analyzed in liver tissues from WT and Hectd3–/– mice on day 2 after infection with F. novicida (F.n.). (H) Liver tissue samples from WT (W1, W2, and W3) and Hectd3–/– mice (H1, H2, and H3) on day 2 after infection with F. novicida and uninfected WT (W) and Hectd3–/– (H) mice were homogenized, and lysates were analyzed for activation and expression of caspase-3, caspase-1, caspase-11, ZBP1, and HECTD3, and phosphorylation of IκBα, STAT1, and STAT3. GAPDH was used as loading control. Each symbol indicates an individual mouse (C, F, and G). Data represent 3 independent experiments and are presented as mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts